Q&M eyes AI and tech investments for future growth
Firm's new AI platform meant to reduce the chance of misdiagnoses, recommend treatment plans in a more objective, transparent way.
Add BT as a preferred source
Singapore
A FLAW in the dental industry lies in how some dentists prescribe treatment plans simply because they prefer certain procedures. This comes at the expense of patients, said Ng Chin Siau, chief executive of Q&M Dental Group.
In 2018, Q&M established a company, EM2AI, to work on artificial intelligence (AI) projects that target pain points such as this. EM2AI is now preparing for clinical trials to get approval from the Health Sciences Authority for its AI platform, under the Class B medical device category.
TRENDING NOW
Think twice about rebuilding that old landed property into a super-big house to max out GFA
More retrenched white-collar workers in Singapore seeking unions’ help
SpaceX’s US$1.75 trillion IPO: How retail investors, including those in Singapore, can buy shares
DBS Research and UOBKH eye Singtel, Venture as top picks for June
